Identification of novel dipeptidyl peptidase 9 substrates by two‐dimensional differential in‐gel electrophoresis
暂无分享,去创建一个
Ruth Geiss-Friedlander | M. Gorrell | A. Stephens | A. Rainczuk | F. Keane | Sadiqa Maqsudi | H. Zhang | J. Lawrence | Nadine Duffield | Daniela Justa‐Schuch
[1] Yiqian Chen,et al. Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin. , 2015, Biochimica et biophysica acta.
[2] O. Schilling,et al. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy , 2014, Proteomics. Clinical applications.
[3] Zhihua Liu,et al. S100 protein family in human cancer. , 2014, American journal of cancer research.
[4] J. Pickard,et al. Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] Ruth Geiss-Friedlander,et al. The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus , 2014, Cellular and Molecular Life Sciences.
[6] Jolon M. Dyer,et al. Evidence for the antagonistic form of CXC‐motif chemokine CXCL10 in serous epithelial ovarian tumours , 2014, International journal of cancer.
[7] Yiqian Chen,et al. Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality , 2013, PloS one.
[8] C. Lenz,et al. The SUMO1-E67 Interacting Loop Peptide Is an Allosteric Inhibitor of the Dipeptidyl Peptidases 8 and 9* , 2013, The Journal of Biological Chemistry.
[9] Yiqian Chen,et al. Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9 , 2013, Molecular Cancer Research.
[10] M. Kirby,et al. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues , 2013, Regulatory Peptides.
[11] M. Condina,et al. The utility of isotope-coded protein labeling for prioritization of proteins found in ovarian cancer patient urine. , 2013, Journal of proteome research.
[12] W. Martinet,et al. Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis , 2013, Basic Research in Cardiology.
[13] T. Kawaguchi,et al. Dipeptidyl peptidase-4: a key player in chronic liver disease. , 2013, World journal of gastroenterology.
[14] C. Overall,et al. Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Reveals in Vivo Roles in Cellular Homeostasis and Energy Metabolism , 2013, The Journal of Biological Chemistry.
[15] F. Melchior,et al. A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation* , 2012, The Journal of Biological Chemistry.
[16] J. Gathercole,et al. The emerging role of CXC chemokines in epithelial ovarian cancer. , 2012, Reproduction.
[17] Yuquan Wei,et al. Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. , 2012, Oncology reports.
[18] S. Unniappan,et al. Nucleobindins: bioactive precursor proteins encoding putative endocrine factors? , 2012, General and comparative endocrinology.
[19] D. Schuppan,et al. When GLP-1 hits the liver: a novel approach for insulin resistance and NASH. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[20] A. Zekry,et al. The long and the short of interferon‐gamma–inducible protein 10 in hepatitis C virus infection , 2011, Hepatology.
[21] P. Quax,et al. The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions , 2011, EMBO molecular medicine.
[22] Jason U Tilan,et al. Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors , 2011, The Journal of Biological Chemistry.
[23] Kang-Yell Choi,et al. A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling , 2011, Molecular Cancer Research.
[24] A. Saghatelian,et al. A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones. , 2011, Biochemistry.
[25] A. Casrouge,et al. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. , 2011, The Journal of clinical investigation.
[26] P. Nicholls,et al. Post-translational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE. , 2010, Journal of proteome research.
[27] A. Saghatelian,et al. Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform. , 2010, Journal of the American Chemical Society.
[28] J. Bines,et al. Proteomic analysis of the intestinal adaptation response reveals altered expression of fatty acid binding proteins following massive small bowel resection. , 2010, Journal of proteome research.
[29] Y. Li,et al. Proteomic identification of caldesmon as a physiological substrate of proprotein convertase 6 in human uterine decidual cells essential for pregnancy establishment. , 2009, Journal of proteome research.
[30] C. Abbott,et al. The In Vivo Expression of Dipeptidyl Peptidases 8 and 9 , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[31] H. Urlaub,et al. The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides* , 2009, The Journal of Biological Chemistry.
[32] A. Tomida,et al. A Novel Endoplasmic Reticulum Export Signal , 2009, The Journal of Biological Chemistry.
[33] Xin Chen,et al. Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. , 2009, Biochemical pharmacology.
[34] B. Honoré. The rapidly expanding CREC protein family: members, localization, function, and role in disease , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.
[35] M. Kirby,et al. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. , 2009, Clinical science.
[36] W. B. Church,et al. Reversible Inactivation of Human Dipeptidyl Peptidases 8 and 9 by Oxidation , 2008 .
[37] B. S. Hamilton,et al. Expression and characterization of human glycosylated interleukin-1 receptor antagonist in Pichia pastoris. , 2008, Protein expression and purification.
[38] C. Overall,et al. Stromal cell‐derived factors 1α and 1β, inflammatory protein‐10 and interferon‐inducible T cell chemo‐attractant are novel substrates of dipeptidyl peptidase 8 , 2008, FEBS letters.
[39] F. Melchior,et al. Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.
[40] Yusuke Nakamura,et al. Nucleobindin 1 Controls the Unfolded Protein Response by Inhibiting ATF6 Activation* , 2007, Journal of Biological Chemistry.
[41] G. McCaughan,et al. Extraenzymatic functions of the dipeptidyl peptidase IV‐related proteins DP8 and DP9 in cell adhesion, migration and apoptosis , 2006, The FEBS journal.
[42] P. F. Nielsen,et al. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV. , 2006, The Biochemical journal.
[43] M. Gorrell. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. , 2005, Clinical science.
[44] E. Friauf,et al. A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue , 2005, Proteomics.
[45] Kathryn S Lilley,et al. All about DIGE: quantification technology for differential-display 2D-gel proteomics , 2004, Expert review of proteomics.
[46] A. Imberty,et al. Heparan Sulfate/Heparin Oligosaccharides Protect Stromal Cell-derived Factor-1 (SDF-1)/CXCL12 against Proteolysis Induced by CD26/Dipeptidyl Peptidase IV* , 2004, Journal of Biological Chemistry.
[47] C. Abbott,et al. Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. , 2004, Biochimica et biophysica acta.
[48] M. Friedlander,et al. Lacryglobin in human tears, a potential marker for cancer , 2001, Clinical & experimental ophthalmology.
[49] N. Tanuma,et al. Up-regulation of I-2(PP2A)/SET gene expression in rat primary hepatomas and regenerating livers. , 2000, Cancer letters.
[50] G. Opdenakker,et al. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. , 1998, Biochemistry.